Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tempest Therapeutics, Inc. (TPST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.53+0.15 (+1.79%)
At close: 04:00PM EST
8.56 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/8/2021
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 341.55
52 Week Low 38.00
50-Day Moving Average 312.31
200-Day Moving Average 317.14

Share Statistics

Avg Vol (3 month) 323.71k
Avg Vol (10 day) 311.48k
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 86.05M
% Held by Insiders 11.26%
% Held by Institutions 131.65%
Shares Short (Oct 28, 2021) 455.15k
Short Ratio (Oct 28, 2021) 43.51
Short % of Float (Oct 28, 2021) 4N/A
Short % of Shares Outstanding (Oct 28, 2021) 40.82%
Shares Short (prior month Sep 29, 2021) 481.99k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 09, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 27, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.34M
Net Income Avi to Common (ttm)-22.16M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.41M
Total Cash Per Share (mrq)10.22
Total Debt (mrq)19.07M
Total Debt/Equity (mrq)39.64
Current Ratio (mrq)7.20
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-15.08M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement